Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction.

J Clin Med · 2022 · PMC9571017 · PMID 36233642

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Our data showed that the differences in hs-CRP deltas between groups did not reach statistical significance.

also in 111,027 other papers

markedly significantno p-value reported

Our study did not find an increase in BNP levels by DPP-4i, but there was a markedly significant decrease in this biomarker during follow-up time in both groups.

also in 476 other papers

a numerical trendno p-value reported

Second, although there was a numerical trend for lower C-reactive protein with DPP-4i, we could not find a statistically significant difference between groups in this marker of inflammation.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.